Finally, the transfection of LOC100506314 effectively suppressed the expression of IL-6 and IL-17 in T cells from patients with vitiligo, which are known to be elevated in the serum of patients with vitiligo [37, 38]. The gene discussed is IL17A; the disease is vitiligo.